tiprankstipranks
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market
ADMA
ADMA Biologics
RESEARCH TOOLSreports
Want to see ADMA full AI Analyst Report?

ADMA Biologics (ADMA) Income Statement

3,020 Followers

ADMA Biologics Income Statement

Last quarter (Q4 2025), ADMA Biologics's total revenue was $139.16M, an increase of 18.39% from the same quarter last year. In Q4, ADMA Biologics's net income was $49.38M. See ADMA Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 510.17M$ 426.45M$ 258.21M$ 154.08M$ 80.94M
Gross Profit
$ 292.76M$ 219.55M$ 88.94M$ 35.27M$ 1.17M
Operating Expenses
$ 101.32M$ 80.57M$ 67.31M$ 74.63M$ 59.55M
Depreciation and Amortization
$ 8.10M$ 8.04M$ 8.33M$ 7.11M$ 5.50M
EBITDA
$ 197.86M$ 147.69M$ 5.12M$ -39.51M$ -53.09M
Operating Income
$ 191.44M$ 138.98M$ 21.63M$ -39.37M$ -58.37M
Other Income/Expenses
$ -8.79M$ -13.27M$ -49.87M$ -26.54M$ -13.27M
Pretax Income
$ 182.66M$ 125.71M$ -28.24M$ -65.90M$ -71.65M
Net Income
$ 146.93M$ 197.67M$ -28.24M$ -65.90M$ -71.65M
Per Share Metrics
Basic EPS
$ 0.62$ 0.85$ -0.13$ -0.43$ -0.61
Diluted EPS
$ 0.60$ 0.81$ -0.13$ -0.43$ -0.61
Weighted Average Shares Outstanding
 238.30M 233.08M 223.98M 197.87M 139.58M
Weighted Average Shares Outstanding (Diluted)
 244.90M 243.34M 223.98M 197.87M 139.58M
Currency in USD

ADMA Biologics Earnings and Revenue History